| Title | Molecular Pharmaceutics |
| Abbreviation | Mol. Pharm. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2) |
| h-index | 156 |
| Overall Rank/Ranking | 4943 |
| SCImago Journal Rank (SJR) | 0.94 |
| Impact Score | 4.78 |
| Publisher | American Chemical Society |
| Country | United States |
| ISSN | 15438384, 15438392 |
| Best Quartile | Q1 |
| Coverage History | 2004-2023 |
Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development
Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science ad they relate to drug and drug delivery system efficacy. Theoretical and experimental peer-reviewed communications, full-length research papers, brief articles, and critical reviews are welcomed.
Molecular Pharmaceutics is a journal covering the technologies/fields/categories related to Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2). It is published by American Chemical Society. The overall rank of Molecular Pharmaceutics is 4943. According to SCImago Journal Rank (SJR), this journal is ranked 0.94. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 156. The best quartile for this journal is Q1.
The ISSN of Molecular Pharmaceutics journal is 15438384, 15438392. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular Pharmaceutics is cited by a total of 5719 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Molecular Pharmaceutics is 4.78, which is computed in 2024 as per its definition. Molecular Pharmaceutics IF is decreased by a factor of 0.22 and approximate percentage change is -4.4% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Molecular Pharmaceutics is 4.78. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4.78 |
| 2022 | 5.00 |
| 2021 | 5.23 |
| 2020 | 4.70 |
| 2019 | 4.44 |
| 2018 | 4.65 |
| 2017 | 4.79 |
| 2016 | 4.93 |
| 2015 | 5.04 |
| 2014 | 5.03 |
Molecular Pharmaceutics has an h-index of 156. It means 156 articles of this journal have more than 156 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Molecular Pharmaceutics is 15438384, 15438392. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Molecular Pharmaceutics is 4943. According to SCImago Journal Rank (SJR), this journal is ranked 0.94. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.94 |
| 2022 | 0.929 |
| 2021 | 0.936 |
| 2020 | 1.130 |
| 2019 | 1.213 |
| 2018 | 1.402 |
| 2017 | 1.572 |
| 2016 | 1.538 |
| 2015 | 1.605 |
| 2014 | 1.641 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4943 |
| 2022 | 4739 |
| 2021 | 4509 |
| 2020 | 3647 |
| 2019 | 3195 |
| 2018 | 2537 |
| 2017 | 2127 |
| 2016 | 2271 |
| 2015 | 2118 |
| 2014 | 1978 |
Molecular Pharmaceutics is published by American Chemical Society. It's publishing house is located in United States. Coverage history of this journal is as following: 2004-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Molecular Pharmaceutics is Mol. Pharm.. This abbreviation ('Mol. Pharm.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Molecular Pharmaceutics latest impact IF is 4.78. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 5.23 (2021) and 4.44 (2019), respectively, in the last 10 years. Moreover, its average IS is 4.86 in the previous 10 years.
The Molecular Pharmaceutics has an SJR (SCImago Journal Rank) of 0.94, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.641 in 2014 and the lowest being 0.929 in 2022. Furthermore, the average SJR of the Molecular Pharmaceutics over the previous 10-year period stands at 4.86.
The latest h-index of the Molecular Pharmaceutics is 156.
The Molecular Pharmaceutics is published by the American Chemical Society, with its country of publication being the United States.
The Molecular Pharmaceutics is currently ranked 4943 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1978 in 2014 and its lowest position of 4943 in 2023.
The standard ISO4 abbreviation for the Molecular Pharmaceutics is Mol. Pharm..
Molecular Pharmaceutics is classified as a journal that the American Chemical Society publishes.
The Molecular Pharmaceutics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Molecular Pharmaceutics is assigned the following International Standard Serial Numbers (ISSN): 15438384, 15438392.
The best quartile for the Molecular Pharmaceutics is Q1 (2023).
The Molecular Pharmaceutics coverage history can be summarized as follows: 2004-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Competition Law and Economics | journal | 10133 | Oxford University Press | 30 | 0.96 |
| Milan Journal of Mathematics | journal | 3538 | Birkhauser Verlag Basel | 29 | 1.14 |
| Discourse | journal | 6196 | Routledge | 65 | 2.36 |
| World Englishes | journal | 3418 | Wiley-Blackwell | 64 | 1.64 |
| Canadian Journal of Education | journal | 18985 | Canadian Society for the Study of Education (CSSE) | 43 | 0.58 |
| Journal, Indian Academy of Clinical Medicine | journal | 26979 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| Journal of Immigrant and Refugee Studies | journal | 8890 | Routledge | 36 | 2.04 |
| Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria | journal | 25905 | National Association of Resident Doctors of Nigeria | 25 | 0.00 |
| Brazilian Symposium of Computer Graphic and Image Processing | conference and proceedings | 16004 | 32 | 0.00 | |
| Journal of Medical Toxicology | journal | 7459 | Springer New York | 58 | 1.58 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 4.78 |
| 2022 | 5.00 |
| 2021 | 5.23 |
| 2020 | 4.70 |
| 2019 | 4.44 |
| 2018 | 4.65 |
| 2017 | 4.79 |
| 2016 | 4.93 |
| 2015 | 5.04 |
| 2014 | 5.03 |
